Trinity Biotech
Stock Forecast, Prediction & Price Target
Trinity Biotech Financial Estimates
Trinity Biotech Revenue Estimates
Trinity Biotech EBITDA Estimates
Trinity Biotech Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $92.96M N/A | $74.77M -19.56% | $56.83M -24.00% | Avg: $71M Low: $71M High: $71M avg. 24.92% | |||
Net Income
% change YoY
| $875K N/A | $-41.00M -4785.94% | $-24.01M 41.42% | Avg: $-9.25M Low: $-9.25M High: $-9.25M avg. 61.45% | |||
EBITDA
% change YoY
| $15.89M N/A | $-8.27M -152.06% | $-24.09M -191.14% | Avg: $1.48M Low: $1.48M High: $1.48M avg. 106.14% | |||
EPS
% change YoY
| $0.2 N/A | -$6.08 -3140% | -$3.14 48.35% | Avg: -$1.04 Low: -$1.04 High: -$1.04 avg. 66.87% | |||
Operating Expenses
% change YoY
| $24.51M N/A | $32.96M 34.46% | $46.49M 41.06% | Avg: $24.47M Low: $24.47M High: $24.47M avg. -47.36% | |||
FAQ
What is Trinity Biotech stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 61.45% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -9.25M, average is -9.25M and high is -9.25M.
What is Trinity Biotech stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 24.92% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $71M, average is $71M and high is $71M.
What is Trinity Biotech stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 66.87% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.04, average is -$1.04 and high is $-1.04.